Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Teva asks FDA to raise the bar on new Copaxone copies
Teva asks FDA to raise the bar on new Copaxone copies
Teva may be at a court’s mercy when it comes to IP protection for its long-lasting multiple sclerosis therapy, Copaxone.
ACADIA Pharmaceuticals Initiates Phase II Study of Pimavanserin in Alzheimer’s Disease Agitation
ACADIA Pharmaceuticals Initiates Phase II Study of Pimavanserin in Alzheimer’s Disease Agitation
SAN DIEGO, CA, USA I October 31, 2016 I ACADIA Pharmaceuticals Inc.
ARIAD Announces U.S. Food and Drug Administration Acceptance of NDA Filing for Brigatinib
ARIAD Announces U.S. Food and Drug Administration Acceptance of NDA Filing for Brigatinib
CAMBRIDGE, MA, USA I October 31, 2016 I ARIAD Pharmaceuticals, Inc.
UK Study Shows rifaximin-α (XIFAXAN® 550mg / TARGAXAN® 550mg) for Hepatic Encephalopathy May Reduce Costs to Healthcare Systems
UK Study Shows rifaximin-α (XIFAXAN® 550mg / TARGAXAN® 550mg) for Hepatic Encephalopathy May Reduce Costs to Healthcare Systems
Norgine B.
Astellas buys Ganymed to boost immuno-oncology pipeline
Astellas buys Ganymed to boost immuno-oncology pipeline
Astellas has agreed to pay €422m upfront to buy Ganymed Pharmaceuticals, a German biopharma company specialising in antibody-based cancer drugs.
Are hormonal contraceptives on the way for men?
Are hormonal contraceptives on the way for men?
Most birth control is designed to be used by women, with the exception of condoms and vasectomies.
Depression drugs sales in the US will reach $4.6 billion by 2025, says GlobalData
Depression drugs sales in the US will reach $4.6 billion by 2025, says GlobalData
The US market for major depressive disorders (MDD) will rise from $2.
Seasonal influenza vaccines market will hit $4.3 billion by 2025, says GlobalData
Seasonal influenza vaccines market will hit $4.3 billion by 2025, says GlobalData
The seasonal influenza vaccine market across the seven major markets (7MM) of the US, France, Germany, Italy, Spain, the UK, and Japan, will rise from $3.
Eisai to initiate phase II clinical study of dual orexin receptor antagonist lemborexant in patients with irregular sleep-wake rhythm disorder and dementia
Eisai to initiate phase II clinical study of dual orexin receptor antagonist lemborexant in patients with irregular sleep-wake rhythm disorder and dementia
TOKYO, Japan I October 28, 2016 I Eisai Co.
AstraZeneca pauses two cancer drug trials' enrolment due to bleeding
AstraZeneca pauses two cancer drug trials' enrolment due to bleeding
AstraZeneca's high hopes for cancer immunotherapy were dented on Thursday as the recruitment of new patients with head and neck cancer into two clinical studies was put on hold, following instance...
Why BROCCOLI could reverse the signs of ageing: Compound in the vegetable 'slows down vision loss and middle-age spread'
Why BROCCOLI could reverse the signs of ageing: Compound in the vegetable 'slows down vision loss and middle-age spread'
Physical signs of ageing could be slowed down by a compound found in broccoli, cabbage and avocado, scientists claim.
Viriom Announces Appointment of New Scientific Advisory Board Member
Viriom Announces Appointment of New Scientific Advisory Board Member
SAN DIEGO, Oct.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand